STOCK TITAN

Henry Schein Inc. - HSIC STOCK NEWS

Welcome to our dedicated news page for Henry Schein (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Henry Schein's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Henry Schein's position in the market.

Rhea-AI Summary
Henry Schein, Inc. (HSIC) to Acquire Majority Interest in TriMed, Forms Strategic Relationship with Extremity Medical LLC
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. (HSIC) Appoints Carole T. Faig as Independent Director, Bringing Extensive Health Care and Finance Expertise
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
management
-
Rhea-AI Summary
Henry Schein, Inc. (Nasdaq: HSIC) celebrates 25 years of its 'Holiday Cheer for Children' program, benefiting over 20,000 underserved children and families worldwide. TSMs have donated clothing, toys, and gift cards, with the latest event hosting 100 children and providing 300 gift cards. The program reflects the company's commitment to community service and is supported by the Henry Schein Cares Foundation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
none
Rhea-AI Summary
Zahn Dental, the dental laboratory business of Henry Schein, Inc. (Nasdaq: HSIC), announces its exclusive distribution of Myerson’s newly launched Trusana™ Premium Denture System. The system is comprised of the Trusana Premium 3D Tooth Resin, Trusana Premium 3D Denture Base Resin, and Trusana Bond Denture Adhesive. The three products work together to create a premium denture with optimal physical properties and esthetics for dental laboratories. Trusana’s patented chemistry delivers an esthetic, unfilled polymer with high flexural strength, fracture toughness, and wear-resistance that helps mirror the beauty and translucency of a natural smile. Trusana resins won a RadTech/UVA Emerging Technology award for additive manufacturing in 2020.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. (Nasdaq: HSIC) scores 100 on the Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index, earning the Equality 100 Award for the eighth consecutive year. The company joins 545 major U.S. businesses with top marks, showcasing a commitment to LGBTQ+ workplace equality. Chairman and CEO Stanley M. Bergman emphasizes the importance of diversity and inclusion in the company's culture, expressing gratitude to the Human Rights Campaign Foundation. The PRIDE & ALLIES employee resource group focuses on fostering an inclusive environment and facilitating conversations around LGBTQ+ equality and inclusion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. (HSIC) will present at Nasdaq's 49th Investor Conference on December 6, 2023, at The May Fair Hotel in London. The live webcast can be accessed at https://investor.henryschein.com/webcasts. Henry Schein is the world's largest provider of health care solutions to office-based dental and medical practitioners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
conferences
Rhea-AI Summary
Henry Schein, Inc. (Nasdaq: HSIC) received a notice from Nasdaq stating it was not in compliance with listing requirements due to the delayed filing of its quarterly report. This delay was caused by information access limitations resulting from a cybersecurity incident. The company has 60 days to submit a plan to come into compliance, but it expects to file the report before the end of November 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. (HSIC) reports stable net total sales growth of 3.1% in Q3 2023. GAAP diluted EPS of $1.05 and non-GAAP diluted EPS of $1.32. Global Dental sales increased by 5.4%, while Global Medical sales decreased by 3.1%. 2023 non-GAAP diluted EPS guidance updated to $4.43 to $4.71 due to softening macroeconomic conditions and a $0.55 to $0.75 business interruption impact from a recent cybersecurity incident.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.35%
Tags
earnings
-
Rhea-AI Summary
Henry Schein, Inc. (Nasdaq: HSIC) will present at several investor conferences in November 2023, including Stifel’s Healthcare Conference, Piper Sandler Conference, and Evercore ISI HealthCONx Conference. The presentations can be accessed via live webcast on the company's investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
conferences
Rhea-AI Summary
Henry Schein, Inc. will release its Q3 2023 financial results on November 13, 2023. The company will provide an update on its earnings expectations for the full-year 2023 and discuss the impact of the cybersecurity incident. The earnings conference call will be available via webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
conferences earnings
Henry Schein Inc.

Nasdaq:HSIC

HSIC Rankings

HSIC Stock Data

9.70B
126.53M
1.01%
101.25%
4.59%
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Wholesale Trade
Link
US
Melville

About HSIC

henry schein, inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. the company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. a fortune 500® company and a member of the s&p 500® and nasdaq 100® indexes, henry schein employs more than 18,000 team schein members and serves more than one million customers. the company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. henry schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and henry schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. the company also offers its customers exclusive, innovative technology solutions, including practice